New Molecular Targeted Therapies Integrated With Radiation Therapy in Lung Cancer

PROVENCIO, Mariano; SANCHEZ, Antonio; GARRIDO, Pilar; VALCARCEL, Francisco
August 2010
Chinese Journal of Lung Cancer;Aug2010, Vol. 13 Issue 8, pC1
Academic Journal
No abstract available.


Related Articles

  • ESMO/ESTRO/ESSO joint symposium: integration of targeted therapies with radiation.  // Annals of Oncology;Sep2008 Supplement 8, Vol. 19, p41 

    The article presents abstracts on the integration of targeted therapies with radiation which include modification of the radiation response of tumours or of normal tissues, lung cancer, and the combination of radiation and anti-EGFR treatments in head and neck cancers.

  • Targeted Therapies in the Treatment of Cancer. Twedell, Diane; Meisheid, Allison M. // Journal of Continuing Education in Nursing;Sep/Oct2005, Vol. 36 Issue 5, p193 

    Focuses on the molecular-targeted therapies in the treatment of cancer. View that cancer is a diverse group of assorted disorders and is a major public health problem; Information that the traditional treatments for cancer include surgery, radiation, and chemotherapy; Information on a new class...

  • New Oncology Strategy: Molecular Targeting of Cancer Cells. Capriotti, Teri // Dermatology Nursing;Jun2005, Vol. 17 Issue 3, p181 

    The article focuses molecular targeting of cancer cells. Chemotherapy, radiation therapy, and biological agents all target cells that are in the process of proliferation. Therefore, both cancer cells and mitotically active healthy cells are subject to the cytotoxic effects of these therapies....

  • Targeted Therapy in Non--Small Cell Lung Cancer. Murer, Bruno // Archives of Pathology & Laboratory Medicine;Oct2008, Vol. 132 Issue 10, p1573 

    The article reports on the targeted therapy in non-small cell lung cancer. It discusses that the purpose of this special section on "Molecular Signatures of Lung and Pleural Tumors," is to depict new methodologic growths in molecular pathology to the general pathologist as well as to the specialist.

  • Research Status on Targeted Therapy for Squamous Cell Lung Cancer. Hong YUAN; Shun LU // Chinese Journal of Lung Cancer;Oct2013, Vol. 16 Issue 10, p559 

    With the research of driver mutations, targeted therapy for lung cancer has made a great progress. Compared with lung adenocarcinoma, treatment of squamous cell lung cancer (SCC) has been far behind. While targeted therapies have improved outcomes for patients with lung adenocarcinoma, such as...

  • Lung Cancer Researchers Aim for AIMP2. Breindl, Anette // BioWorld Today;4/4/2011, Vol. 22 Issue 64, Special section p1 

    The article discusses a study by researchers at Korean Seoul National University which examined a new potential target for lung cancer therapies.

  • Advances in Treatment of Lung Cancer With Targeted Therapy. Cagle, Philip T.; Chirieac, Lucian R. // Archives of Pathology & Laboratory Medicine;May2012, Vol. 136 Issue 5, p504 

    Context.-Ongoing preclinical investigations and clinical trials involving new targeted therapies promise to improve survival for patients with lung cancer. Targeted therapeutic agents, based on genetic mutations and signaling pathways altered in lung cancer, have added significantly to our...

  • Opportunities and Challenges in the Era of Molecularly Targeted Agents and Radiation Therapy. Lin, Steven H.; George, Thomas J.; Ben-Josef, Edgar; Bradley, Jeffrey; Choe, Kevin S.; Edelman, Martin J.; Guha, Chandan; Krishnan, Sunil; Lawrence, Theodore S.; Quynh-Thu Le; Bo Lu; Mehta, Minesh; Peereboom, David; Sarkaria, Jann; Jinsil Seong; Dian Wang; Welliver, Meng X.; Coleman, C. Norman; Vikram, Bhadrasain; Yoo, Stephen // JNCI: Journal of the National Cancer Institute;5/15/2013, Vol. 105 Issue 10, p686 

    The first annual workshop for preclinical and clinical development of radiosensitizers took place at the National Cancer Institute on August 8-9, 2012. Radiotherapy is one of the most commonly applied and effective oncologic treatments for solid tumors. It is well recognized that improved...

  • Oncogenic drivers, targeted therapies, and acquired resistance in non-small-cell lung cancer. Gower, Arjan; Wang, Yisong; Giaccone, Giuseppe // Journal of Molecular Medicine;Jul2014, Vol. 92 Issue 7, p697 

    In the past decade, a shift toward targeted therapies in non-small-cell lung cancer following molecular profiling has dramatically changed the way advanced adenocarcinoma is treated. However, tumor cells inevitably acquire resistance to such therapies, circumventing any sustained clinical...

  • Targeting Therapies in the Management of Breast Carcinoma. Kaur, Paramjeet; Chauhan, Ashok K.; Singh, Gajender; Kataria, Sant Parkash // Internet Journal of Oncology;2009, Vol. 6 Issue 2, p23 

    One of the oldest molecular target approaches in breast cancer is the targeting of the estrogen receptor with tamoxifen which is responsible for improvement in outcome, reduced the risk of new primary breast cancer and improves survival. Targeted therapies are now a component of treatment for...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics